compounded semaglutide crackdown news today FDA Warns on Certain Forms of FDA restricts non-approved compounded GLP-1
Description
Conditions that may be grounds for a lawsuit include: Vision loss or changes Ileus and intestinal blockages Necrotizing pancreatitis Pulmonary embolisms Deep vein thrombosis (DVT) Gastric distress including severe or permanent stomach paralysis Surgical complications Potential dangers of compounded semaglutide While the compounded versions of Semaglutide drugs are legal, they do not have FDA approval like the non-compounded versions do
Inject on Saturday this week, then Saturday next week, and every week after
At 0.5 to 2 mg, the dose is low enough that many people report feeling almost nothing for the first few days
Research suggests that some people may regain weight after stopping Wegovy
But some do
